Managed care organizations must move beyond early, low-risk artificial intelligence (AI) use to strategically governed, ...
Rising Specialty Drug Costs and Co-Pay Models Raise Access Concerns: Patty Taddei-Allen, PharmD, MBA
In addition to the models, Taddei-Allen also pointed out the overall shift in employer plan drug costs, shifting more of the ...
Results released April 1, 2026, by the American Society for Radiation Oncology (ASTRO), which represents more than 10,000 ...
Adam Colburn, JD, highlights 3 federal bills to expand value-based care, digital therapeutics, and pharmacist reimbursement ...
A comprehensive approach is necessary for navigating the highly heterogeneous nature of leukemia across different age ...
Steven Kheloussi, PharmD, explains how care coordination and transparent policies can improve MS treatment adherence, ...
EHR validation in 406,230 “relaxed” and 127,151 “strict” patients showed stable PREVENT discrimination across sexes, ...
IGHV mutational status has long been used by clinicians to predict how CLL will behave and when treatment may be needed. 2 ...
A 1000 mg ×2 induction regimen followed by maintenance every 6–12 months was associated with near-elimination of relapse ...
A breast cancer diagnosis doesn't land only on the patient, but rather it ripples through an entire household. In this ...
Prior authorization was rated a major burden by 32% of insured adults and the single greatest barrier by 34%, surpassing ...
A new case-control study published in JAMA Cardiology demonstrates that molecular imaging using gallium-68–labeled fibroblast ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results